Skip to main content

Bias and spin in reporting trials of new drugs for breast cancer

A paper published this week in the Annals of Oncology has demonstrated bias in the reporting of  outcome and toxicity of phase 3 randomized controlled trials (RTCs) for breast cancer. These trials are the final stage of testing of the efficacy and toxicity of a new drug or treatment before approval by regulatory agencies.

Papers published in scientific and medical journals have an abstract, a summary of the findings, and it is in this that the results are often presented in a biased way. Of the reports of 164 trials they reviewed, 33% of them showed bias in the reporting of the primary end point (PE) and as many as 67% in reporting the toxicity. Bias in reporting of outcome is common for studies with negative PEs.  Reporting of toxicity is poor, especially for the studies with positive PEs. It isn't that the authors don't give the correct result in the body of the report. The problem is that they put a 'spin' on them.    It is shocking but perhaps the finding is not surprising.

It is often argued that science is 'ethically neutral'. I have never subscribed to such a view. There isn't an ideal position of neutrality;somewhere from which we can see things free from assumptions or even prejudice. There is always a view from somewhere; a perspective that influences the way in which we see or interpret apparently objective data. In short there isn't a view from nowhere.

Science tests ideas, usually by first framing them into clearly testable hypotheses. What this tells us is that science is a human activity, it isn't a body of knowledge existing in some rarefied library. As soon as we touch it we frame it. We bring it into our world view.  It is also the case that science rarely if ever produces definitive answers. For all studies there are caveats; it might be difficult to control or account for all possible variables. This always provides leeway in interpretation of results and it is here that bias and spin are often in play.

Emphasising the positive over the negative in results is a judgement. In the case of Phase 3 human trials such judgement can have significantly harmful consequences. Ethical science isn't simply a matter of 'getting the right result' or the 'result right'. Ethical science should always be alert to its vulnerabilities. It has motive, it involves perspective and decision. Where there are choices there must always be ethical consideration. Scientists should consider the consequences of any bias they may introduce into their reports.

Comments

Popular posts from this blog

Bad trade kills the planet.

One problem with the financial crisis of 2008/9 is that it focused attention on the banking system as if it could be separated from global economics.  It fostered the notion that all that was needed was to reform the banks and all would be well.  The underlying assumption was and is that global economics didn't and doesn't need fixing.  Everything works well but for the financial system.  Let's all keep calm and carry on.

Yet, the focus on a bad banking system hides an underlying economic malaise,  The economy depended on banks lending, and growth was predicated on debt, debt and more debt.  This was not simply a problem of the banking system.  It was, and remains a problem arising from the mythology of economic growth.

Politicians have long fostered the mythology of growth.  Growth became a  mantra.  Growth is good.  Good is growth.  Let's grow! Growth as and is presented as a miraculous cure.

Let's call this the first neoliberal myth.  The second neoliberal myth…

Hummingbird exposure to pesticides

Many have responded to the campaigns to stop the use of pesticides killing bees.  Bees are not the only animals affected.

Hummingbirds are noted as a species of conservation concern by Partners in Flight, and their populations are estimated to have declined by 60% between 1970 and 2014.



New research reveals that hummingbirds and bumble bees are being exposed to neonicotinoid and other pesticides through routes that are widespread and complex. The findings are published in Environmental Toxicology & Chemistry.

To measure exposure to pesticides in these avian pollinators, investigators made novel use of cloacal fluid and fecal pellets from hummingbirds living near blueberry fields in British Columbia. They also collected bumble bees native to Canada, and their pollen, and blueberry leaves and flowers from within conventionally sprayed and organic blueberry farms.

The researchers detected pesticides and related compounds in cloacal fluid and fecal pellets of hummingbirds revealing…

Brexit won't save the planet

Brexit isn't an ideal. It might break the cosy economic and political illusion that all growth and trade is good. But there is little thinking behind it. It won't lead to better trade. It won't save our planet.



No plan for Brexit The UK is  now just months away from leaving the European Union, yet still the government has no plan for Brexit. Sector after sector of British society are registering their concerns about the consequences of a 'no deal' Brexit.  The country is in the dark about what the future might hold.  Key issues remain unresolved, yet it is as if it doesn't matter.   Brexit, remember, means Brexit!  
Whether we are for or against Brexit we should be concerned that the government can't agree on what kind of deal they want with our biggest trading partner - the European Union.  
There is no idealism behind Brexit, and no vision for the future.  Instead, there is a blind hope that it will be 'alright on the night'.  That somehow a…